Work

Sa1086 Dose Escalation of Vedolizumab From Every 8 Weeks to Every 4 or 6 Weeks Enables Patients With Inflammatory Bowel Disease to Recapture Response

Year: 2016

Type: conference-abstract

Source: Gastroenterology

DOI: 10.1016/s0016-5085(16)30859-9

Authors: Antonio H. Mendoza Ladd, Frank I. Scott, Rory Grace, Hillary Bownik, Gary R. Lichtenstein

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2341274477

Cites:

Cited by: 6

Related to: 10